Achilles Therapeutics plc Quarterly Liabilities, Current in USD from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Achilles Therapeutics plc quarterly Liabilities, Current history and growth rate from Q4 2020 to Q2 2024.
  • Achilles Therapeutics plc Liabilities, Current for the quarter ending June 30, 2024 was $14.3M, a 25.2% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $14.3M -$4.82M -25.2% Jun 30, 2024 6-K 2024-08-14
Q4 2023 $17M -$997K -5.54% Dec 31, 2023 6-K 2024-08-14
Q2 2023 $19.1M Jun 30, 2023 6-K 2023-08-04
Q4 2022 $18M -$1.12M -5.85% Dec 31, 2022 20-F 2024-04-04
Q4 2021 $19.1M +$2.49M +15% Dec 31, 2021 20-F 2023-03-07
Q4 2020 $16.6M Dec 31, 2020 20-F 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.